Llwytho...
Bimatoprost Implant: First Approval
Bimatoprost implant (Durysta™), developed by Allergan, is a sustained-release drug delivery system containing bimatoprost, a prostaglandin analogue with ocular hypotensive activity. The implant, administered intracamerally, involves the use of a biodegradable, solid polymer drug delivery system for...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Drugs Aging |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer International Publishing
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303088/ https://ncbi.nlm.nih.gov/pubmed/32447639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-020-00769-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|